Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105584

Cerebral Blood Flow and Metabolism in the Wernicke-Korsakoff Syndrome

Sadatomo Shimojyo, Peritz Scheinberg, and Oscar Reinmuth

Department of Neurology, University of Miami School of Medicine, Miami, Fla.

†

Address requests for reprints to Dr. Peritz Scheinberg, Dept. of Neurology, University of Miami, 1601 N. W. 11th Ave., Miami, Fla. 33136.

*

Submitted for publication September 1, 1966; accepted February 1, 1967.

Supported by U. S. Public Health Service grant NB 05820-01.

Find articles by Shimojyo, S. in: PubMed | Google Scholar

Department of Neurology, University of Miami School of Medicine, Miami, Fla.

†

Address requests for reprints to Dr. Peritz Scheinberg, Dept. of Neurology, University of Miami, 1601 N. W. 11th Ave., Miami, Fla. 33136.

*

Submitted for publication September 1, 1966; accepted February 1, 1967.

Supported by U. S. Public Health Service grant NB 05820-01.

Find articles by Scheinberg, P. in: PubMed | Google Scholar

Department of Neurology, University of Miami School of Medicine, Miami, Fla.

†

Address requests for reprints to Dr. Peritz Scheinberg, Dept. of Neurology, University of Miami, 1601 N. W. 11th Ave., Miami, Fla. 33136.

*

Submitted for publication September 1, 1966; accepted February 1, 1967.

Supported by U. S. Public Health Service grant NB 05820-01.

Find articles by Reinmuth, O. in: PubMed | Google Scholar

Published May 1, 1967 - More info

Published in Volume 46, Issue 5 on May 1, 1967
J Clin Invest. 1967;46(5):849–854. https://doi.org/10.1172/JCI105584.
© 1967 The American Society for Clinical Investigation
Published May 1, 1967 - Version history
View PDF
Abstract

Cerebral blood flow and metabolism were measured by the iodoantipyrine-4-131I method in nine patients and by the nitrous oxide method in three patients with the Wernicke-Korsakoff syndrome.

Cerebral blood flow and cerebral oxygen and glucose consumption were strikingly reduced from the normal, whereas cerebral vascular resistance was increased.

Total cerebral metabolism and blood flow may be greatly reduced even though the cerebral metabolic defect is confined to circumscribed anatomical areas. Profound reduction in brain metabolism is not necessarily reflected in alterations of consciousness or awareness as has been previously suggested, or in electroencephalographic abnormalities. This appears to provide cogent support for the neurophysiological principle that disturbance of consciousness is a function of the location of the lesion, not the over-all degree of metabolic defect.

The absence of improvement of cerebral metabolic functions in two patients who were restudied after an additional 2 to 3 weeks of treatment confirms the clinical impression of incomplete recovery in many such patients.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 849
page 849
icon of scanned page 850
page 850
icon of scanned page 851
page 851
icon of scanned page 852
page 852
icon of scanned page 853
page 853
icon of scanned page 854
page 854
Version history
  • Version 1 (May 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts